Ghrelin Changes After Roux-en-Y Gastric Bypass

NCT ID: NCT00765596

Last Updated: 2011-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

14 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether gastric division (via Roux-en-Y gastric bypass) with resultant fundic isolation will alter the pattern(s) of Ghrelin secretion in the early post-operative period following feeding in morbidly obese subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Insulin Resistance

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Obesity Insulin resistance Gastric tube Ghrelin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1 RYGB

Subjects undergoing RYGB with gastric tube placement

No interventions assigned to this group

2 Matched controls

Subjects matched by BMI, age, gender to RYGB group

Liquid diet for 3 days

Intervention Type OTHER

The control group were given a 3 -day liquid diet similar to the RYGB post-op diet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Liquid diet for 3 days

The control group were given a 3 -day liquid diet similar to the RYGB post-op diet

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Serum creatinine and liver function tests \< upper limits of normal
* Stable body weights for the past three months
* Women will have a negative pregnancy test
* patients who are already scheduled for RYGB with gastrostomy tube placement

Exclusion Criteria

* Significant hepatic enzyme elevations (more than 100% of upper limits of normal)
* Serum creatinine \> 1.5 mg/dl
* history of ketoacidosis or current metabolic acidosis
* current use of oral anticoagulants
* Positive pregnancy test (beta-human chorionic gonadotrophin) for females
* intercurrent infections
* patients with prior gastric operations
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vanderbilt University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Naji Abumrad

Chairman, Department of Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Naji N Abumrad, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Surgery, Vanderbilt University Medical Center

Erik N Hansen, MD

Role: PRINCIPAL_INVESTIGATOR

Departement of Surgery, Vanderbilt University Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Hansen EN, Tamboli RA, Isbell JM, Saliba J, Dunn JP, Marks-Shulman PA, Abumrad NN. Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G795-802. doi: 10.1152/ajpgi.00019.2011. Epub 2011 Mar 3.

Reference Type DERIVED
PMID: 21372167 (View on PubMed)

Isbell JM, Tamboli RA, Hansen EN, Saliba J, Dunn JP, Phillips SE, Marks-Shulman PA, Abumrad NN. The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care. 2010 Jul;33(7):1438-42. doi: 10.2337/dc09-2107. Epub 2010 Apr 5.

Reference Type DERIVED
PMID: 20368410 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB#041129

Identifier Type: -

Identifier Source: org_study_id